Evidence map›Paper›PMID 40045658›Full record

ArticleCPT: pharmacometrics & systems pharmacology2025

Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit.

Leticia Arrington, Sven C van Dijkman, Elodie L Plan, Mats O Karlsson

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leticia ArringtonDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0001-7272-1657
Sven C van DijkmanDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-2799-7643
Elodie L PlanDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-2255-3904
Mats O KarlssonDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0003-1258-8297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 15% of patients suspected of having Parkinson's disease (PD) present dopamine active transporter (DaT) scans without evidence of dopaminergic deficits (SWEDD), most of which will never develop PD. Leveraging Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores from the Parkinson's Progression Markers Initiative, three different models of varying complexity, (total score, item response theory (IRT) and artificial neural network (ANN)) were evaluated to determine their ability to differentiate between PD and SWEDDs. Each of the models provided as output a predicted probability of having PD (P

Indexed as

DopamineDopamine Plasma Membrane Transport ProteinsNeural Networks, ComputerParkinson DiseaseAgedFemaleHumansMaleMiddle AgedDopamineDopamine Plasma Membrane Transport Proteinsclassificationdiscrete data modelsdisease progressionitem response theorymachine learningmixed effect modelsneuroscienceParkinson's diseasepharmacometrics

Identifiers

PMID40045658
PMCPMC12072227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.